Qiming Venture Partners

Qiming Venture Partners is a prominent venture capital firm established in 2006 and headquartered in Shanghai, with additional offices in Beijing, Suzhou, and Hong Kong. The firm specializes in investing in early to growth-stage companies across various sectors, including media and internet, information technology, consumer and retail, healthcare, and clean technology in China. Since its inception, Qiming has built a reputation as a leading investment firm in the region, managing multiple funds with over $1 billion in assets. The firm aims to support promising entrepreneurs and innovative businesses, contributing to the development of China's dynamic economic landscape.

Artavazd Arumov Ph.D

Principal

Ryan Baker

Chief Financial Officer

Sam Chen

Associate

Nan Chen

Principal

Phil DiGiacomo

VP

Anna French

Partner

Jinda Gao

Executive Director

William Hu

Managing Partner

Duane Kuang

Co-Founder & Managing Partner

Grace Lee

Partner

Nisa Leung

Managing Partner

Shuo Mao

vice_president

Mark McDade

Partner

Will Mcconnell

VP

Gary Rieschel

Co-Founder & Managing Partner

Amy Tang

Venture Partner

Shiyu Wang

Partner

Bonnie Wang

Principal

Jing Wu

Partner

Kuantai Yeh

Partner

Janet Yu Ph.D

Partner

Oscar Zhang

Principal

Alex Zhou

Partner

Past deals in Series C

EigenCOMM

Series C in 2022
Eigencomm is dedicated to the development and sales of cellular IoT chips.

Zhenge Biotech

Series C in 2022
Shanghai ZhenGe Biotechnology Co.,Ltd. researches and develops drugs. It also engages in mammalian cell line development, upstream development, downstream development, and formulation development for various protein therapeutics. In addition, the company provides contract development and manufacturing services; and offers IND and BLA filing services. Further, it provides platform for research and development of antibodies, transient infection, process development, N-Glycosylation, and CAR-T. Shanghai ZhenGe Biotechnology Co.,Ltd. was founded in 2017 and is based in Shanghai, China.

Abogen Biosciences

Series C in 2021
Abogen Biosciences is a discovery stage biotechnology company focuses on developing nucleic acid-based (RNA and DNA) therapeutics for treatment of cancer and infectious diseases.

Liangyihui

Series C in 2021
Suzhou Liangyihui Network Technology Co., Ltd. develops anti-cancer academic platform for cancer patients. The company is based in Shanghai, China.

Insilico Medicine

Series C in 2021
Insilico Medicine, Inc. is an artificial intelligence company based in Rockville, Maryland, specializing in drug discovery, biomarker development, and aging research. Founded in 2014, the company leverages advanced AI techniques, including generative adversarial networks and deep learning, to create novel molecular structures for various diseases. Insilico Medicine has developed a comprehensive end-to-end pipeline for drug discovery, which encompasses all stages from initial research to clinical trials. Its notable platforms include Pharma.AI, which offers machine learning services to various sectors, and Young.AI, which integrates predictors of age. The company is actively engaged in internal drug discovery programs targeting conditions such as cancer, Alzheimer's disease, and diabetes. Additionally, Insilico Medicine has partnered with Life Extension to produce nutraceutical products using bioinformatics and deep learning. It serves a diverse clientele, including academia, pharmaceutical companies, and cosmetic firms, while also providing consumer-facing applications to enhance health and longevity.

Yidao Biotechnology

Series C in 2021
Yidao Biotechnology research and develops vaccines and biomedical products. It focuses on the research and development of a variety of vaccines such as recombinant protein antigen vaccine, new virus vector vaccine, messenger RNA vaccine, and vaccine adjuvant platforms, providing vaccines to meet the needs of human health in both domestic and international markets. The Suzhou, Jiangsu-based biotech company was established in 2017.

TUNGEE

Series C in 2021
Guangzhou Tungee Technology Co.,Ltd., a software as a service (SaaS) company, develops intelligent sales cloud platform. It provides leads mining, business opportunity engagement, customer relationship management, and order analysis for enterprises. The company offers Tungee intelligent sales cloud platform , outbound leads, inbound leads, engage, cloud-based call center, intelligent call, and CRM products. It also offers Tungee galaxy, prophecy, and discernment solutions. Guangzhou Tungee Technology Co.,Ltd. was founded in 2016 and is based in Panyu, China.

PR Measurement

Series C in 2021
P&R Measurement Technology Co., Ltd., established in 2011 and based in Zhuhai, China, specializes in the research, development, and application of advanced measurement and control technology. The company provides testing and automation solutions across various sectors, including motors, household appliances, consumer electronics, and energy power. With over 300 independent intellectual property rights, P&R Measurement has earned recognition as a national high-tech enterprise and has received multiple certifications, including ISO9001:2015. The firm focuses on engineering signal processing, acoustic and vibration testing, and structural analysis, offering custom and semi-custom testing equipment and consulting services. P&R Measurement also collaborates with universities and research institutions to enhance its technological capabilities. It operates subsidiaries in multiple locations, including Guangzhou, Suzhou, Hong Kong, and the United States, and has developed comprehensive solutions that are widely acknowledged by industry clients, contributing to its reputation in the testing and automation landscape.

SinoUnited Health

Series C in 2021
SinoUnited Health is a medical center based in Shanghai, China, specializing in sports medicine, physical therapy, pain management, orthopaedics, and neurology services. Established in 2004, the center offers a comprehensive range of treatments, including services for foot and ankle issues, acupuncture, chronic pain management, movement disorders, migraines, tremors, electromyography, balance training, and post-stroke care. The facility is designed to provide a comfortable environment that meets international standards, ensuring a high-quality experience for patients. SinoUnited Health has built a strong reputation for delivering reliable diagnoses and effective treatment outcomes, reinforcing its commitment to enhancing patient satisfaction and well-being within the community.

Castbox

Series C in 2021
Castbox is an award-winning global podcast platform that enables anyone to easily find, access, create and enjoy spoken audio content. Castbox gives users access to endless content in multiple languages, anywhere, through any device. Castbox’s proprietary technology includes features like curated podcast recommendations and in-audio deep search to customize the listening experience.

Matrixport

Series C in 2021
Matrixport is your gateway to digital economy where you can trade, custody, invest and borrow crypto assets all in one stop. With rich industry resources and leading technology capabilities, Matrixport aims to create the next generation digital financial service platform. Their vision is to enable a more open and equal financial system using blockchain technologies. Matrixport has launched trading, digital asset custody, and cryptocurrency lending service for clients around the world, with even more innovative product offerings to come. Matrixport is headquartered in Singapore with offices worldwide.

Booming Tech

Series C in 2021
Booming Tech is a cloud-based platform that specializes in game development and virtual reality. It provides tools for creators to design and innovate within virtual environments, catering to various applications, including gaming, industrial simulations, and other immersive experiences. The platform features a robust server architecture that ensures players can engage in real-time, stable interactions regardless of their geographical locations. By focusing on both entertainment and practical applications, Booming Tech supports a diverse range of virtual world creation, enabling users to explore new possibilities in digital interaction.

Newsoara

Venture Round in 2021
Newsoara is a biomedical technology developer that specializes in the development of medical devices.

Yuanbao Tech

Series C in 2021
Beijing Yuanbao Technology Co., Ltd., a technology company, provides cyber security assessment consulting, network security detection, and cyber security insurance solutions. It offers network security risk monitoring and evaluation, and network security defense system construction advisory services; risk assessment and risk mitigation solutions; model development and technical services for cyber security insurance products for insurance and reinsurance companies; assists insurance companies to conduct cyber security risk assessment for insured customers. The company was founded in 2018 and is based in Beijing, China.

Liangyihui

Series C in 2021
Suzhou Liangyihui Network Technology Co., Ltd. develops anti-cancer academic platform for cancer patients. The company is based in Shanghai, China.

Yunji Technology

Series C in 2021
Yunji Technology is a Chinese robot company that builds a commercial service robot capable of delivering goods.

Insight Lifetech

Series C in 2020
Insight Lifetech Co., Ltd. (Shenzhen) is headquartered in China.

dMed

Series C in 2020
dMed Company Limited, also known as, dMed Biopharmaceutical Co., Ltd. operates as clinical contract research organization providing services for development of medicines and medical devices. The company offer services, including consulting, clinical operations, biostatistics & programming, data management, pharmacovigilance, clinical science & medical affairs, quality assurance, and regulatory affairs & Strategy. It serves biopharmaceutical and medical device companies. dMed Company Limited was founded in 2016 and is based in Shanghai, China.

Nice Tuan

Series C in 2020
Nice Tuan is an e-commerce platform that specializes in providing daily groceries and a variety of household products. The company collaborates with local residential communities to source items from nearby warehouses and producers, ensuring a wide selection of fresh produce and essential goods for residents. By focusing on creating a convenient and efficient community e-commerce ecosystem, Nice Tuan aims to enhance the shopping experience for local consumers while supporting local suppliers.

ZEGOCLOUD

Venture Round in 2020
Shenzhen Zego Technology Co., Ltd. is a company based in Shenzhen, China, that specializes in real-time cloud streaming services for audio and video communications. Founded in 2015, Zego offers a comprehensive platform that supports various functionalities, including one-to-one video calls, live broadcasting, and multi-party video conferencing. The platform also provides services for real-time audio streaming, voice chatrooms, and recording and archiving of events such as bank account openings and interviews. Zego targets enterprise and mobile application developers, focusing on delivering stable and high-quality voice and video services across diverse sectors, including social media, online education, and telemedicine. Additionally, the company provides a software development kit (SDK) to facilitate the integration of its services into other applications.

BRONCUS

Series C in 2020
Broncus Technologies is a medical technology company focused on developing minimally-invasive medical devices for emphysema and other lung diseases. Broncus is investigating the Exhale emphysema product line to perform our patented treatment method called Airway Bypass. Airway Bypass could be the first minimally-invasive procedure for the treatment of homogeneous, or diffuse, emphysema, which constitutes the majority of the emphysema patient population. Broncus is currently enrolling patients worldwide in our pivotal EASE Trial investigating a treatment of severe homogeneous emphysema. Broncus is located in Mountain View, CA (San Francisco Bay area). Broncus International is located in Nyon, Switzerland.

Petkit

Series C in 2020
Shanghai PETKIT Network Technology Co., Ltd. Develops and manufactures pet care products. It offers smart antibacterial bowls, smart feeders, smart drinking fountains, pet accompanying cups, smart leashes, smart cat brand dog tags, smart pet companions, multifunctional cat claw plates, etc.; cat and dog tags that record, analyze, and track the pet's usual sports behavior data; and toys. Shanghai PETKIT Network Technology Co., Ltd. was founded in 2013 and is based in Shanghai, China.
Suzhou Connect Biopharmaceuticals, Ltd., a clinical-stage company, discovers and develops novel medicines for the treatment of autoimmune diseases and inflammation. Its products in pipeline includes CBP-307, an orally-active, second-generation S1P1 agonist for the treatment of a range of autoimmune diseases, including inflammatory bowel disease, graft-versus-host disease, psoriasis, and multiple sclerosis; CBP-174 for allergic rhinitis and atopic dermatitis; and CBP-201, a novel monoclonal antibody for the treatment of atopic dermatitis, asthma, and other types of allergic inflammation. The company is headquartered in Taicang, China with operations in Melbourne and San Diego.

Antengene Corporation

Series C in 2020
Antengene Corporation is a biopharmaceutical company based in Shanghai, China, founded in 2016. The company specializes in developing innovative oncology therapies aimed at treating various types of cancer. Its product pipeline includes ATG-008, an orally available mTOR kinase inhibitor for advanced solid tumors and hematological malignancies, and ATG-010, a compound targeting the XPO1 protein for hematologic cancers like multiple myeloma. Additionally, Antengene is advancing several other candidates in different stages of development, including ATG-016, ATG-527, and ATG-019, which target various oncological conditions. The company is committed to addressing unmet medical needs in Asia through its research and development efforts focused on anti-tumor and anti-cancer therapies.

Nice Tuan

Series C in 2020
Nice Tuan is an e-commerce platform that specializes in providing daily groceries and a variety of household products. The company collaborates with local residential communities to source items from nearby warehouses and producers, ensuring a wide selection of fresh produce and essential goods for residents. By focusing on creating a convenient and efficient community e-commerce ecosystem, Nice Tuan aims to enhance the shopping experience for local consumers while supporting local suppliers.

LetsGetChecked

Series C in 2020
LetsGetChecked is an at-home health testing platform that connects customers to regulated laboratory testing to better manage and control one's individual health. LetsGetChecked is making healthcare and diagnostics open and patient-led, empowering people to use technology in a simple yet powerful way. This offers consumers greater control over their individual health. LetsGetChecked is headquartered in New York, NY, with tests covering general wellness, sexual health, women's health and men's health, and is available nationwide, as well as in Canada and Europe.

Pratilipi

Series C in 2020
Pratilipi is a platform which brings readers, writers and their stories together. From the next door neighbour reading stories in the afternoon, to the funny college kid downstairs, millions of people around you are using Pratilipi to discover, express and share their stories in the language they love.

Yunyinggu

Series C in 2020
Yunyinggu Technology Co., Ltd. is a start-up company dedicated to developing and promoting new display technologies that can significantly improve the performance of flat panel displays. The company's proprietary solution is the world's best in achieving high PPI (pixel per inch) and can be applied to all kinds of flat panels such as LCD, LED, OLED and others. Yunyinggu Technology Co., Ltd. is based in China.

Shulan Health

Series C in 2020
Shulan Hospital is a hospital center that provides rehabilitation, nutrition, health examination, and remote-consultation services.

DiNovA Medtech

Series C in 2020
Weiqiang Medical Technology develops vascular intervention technology for the treatment of aneurysm. Weiqiang Medical Technology specializes in researching and developing innovative vascular dilation products including aortic stent graft system, intraoperative stent system, peripheral vascular stent, and other supporting medical devices, aiming to provide advanced, effective medical solutions for the complicated treatments of various aortic vascular diseases.

Abbisko Therapeutics

Series C in 2020
Abbisko Therapeutics Co. Ltd. discovers, develop, and manufactures immuno-oncology therapies. It offers ABSK011 and ABSK021, which are molecule inhibitors for treating hepatocellular carcinoma; and CSF1R for the treatment of solid tumors. The company also develops therapeutics for the treatment of cancer, tumor, and diabetes, metabolic diseases, liver diseases, viral infections and CNS diseases. The company was founded in 2016 and is based in is based in Shanghai, China.

Element Science

Series C in 2020
Element Science is a medical device and digital health company that develops solutions at the intersection of clinical-grade wearable devices, machine learning algorithms, and lifesaving therapies to address the needs of high-risk cardiovascular patients, primarily as they transition from the hospital to home. The company developing a proprietary next-generation wearable digital platform that unites patient-centric human factor engineering, sophisticated machine learning algorithm development principles, and rigorous electromechanical medical device development standards. The company was founded in 2011 and is headquartered in San Francisco, California.

IntoCare

Series C in 2020
IntoCare is a high-tech company focused on the development of advanced medical devices for surgical procedures. The company specializes in powered surgical staplers, offering both reusable and disposable stapler handles. IntoCare aims to enhance surgical practices by providing reliable, intelligent, and user-friendly instruments. Through its research and development efforts, the company seeks to advance the field of surgical technology and support the marketing of nonpharmaceutical interventions, ensuring that healthcare professionals have access to innovative tools that improve patient outcomes.

Jacobio Pharmaceuticals

Series C in 2020
Jacobio Pharmaceuticals Co., Ltd., a clinical-stage pharmaceutical company, focusing on the in-house discovery and development of oncology therapies. Its lead drug development programs include two clinical-stage allosteric SHP2 inhibitors, including JAB-3068, a SHP2 inhibitor for the treatment of patients with solid tumor; and JAB-3312, an oral small molecule anti-tumor agent. The company was founded in 2015 and is based in Beijing, China. Jacobio Pharmaceuticals Co., Ltd. is a subsidiary of Jacobio (HK) Pharmaceuticals Co., Limited.

DST Car

Series C in 2020
DiShangTie Car Rental (Shenzhen) Co., Ltd. is a Shenzhen-based company that specializes in the rental and maintenance of commercial electric vehicles (EVs) for both passenger and cargo transportation in China. Founded in 2015, the company also manufactures electric car charging stations, catering to the growing demand for sustainable transportation solutions. By focusing on the transportation and logistics industry, DiShangTie aims to facilitate the adoption of new energy vehicles in the region.

KeChow Pharma

Series C in 2019
Shanghai Kechow Pharma, Inc. is a biopharmaceutical company established in 2014 and headquartered in Shanghai, China. The company specializes in the discovery of targeted small molecule drugs, aiming to develop innovative therapies that improve upon existing treatments. KeChow Pharma collaborates with various partners to co-develop its drug candidates, emphasizing a commitment to advancing healthcare through novel therapeutic solutions.

DiNovA Medtech

Series C in 2019
Weiqiang Medical Technology develops vascular intervention technology for the treatment of aneurysm. Weiqiang Medical Technology specializes in researching and developing innovative vascular dilation products including aortic stent graft system, intraoperative stent system, peripheral vascular stent, and other supporting medical devices, aiming to provide advanced, effective medical solutions for the complicated treatments of various aortic vascular diseases.

SinoUnited Health

Series C in 2019
SinoUnited Health is a medical center based in Shanghai, China, specializing in sports medicine, physical therapy, pain management, orthopaedics, and neurology services. Established in 2004, the center offers a comprehensive range of treatments, including services for foot and ankle issues, acupuncture, chronic pain management, movement disorders, migraines, tremors, electromyography, balance training, and post-stroke care. The facility is designed to provide a comfortable environment that meets international standards, ensuring a high-quality experience for patients. SinoUnited Health has built a strong reputation for delivering reliable diagnoses and effective treatment outcomes, reinforcing its commitment to enhancing patient satisfaction and well-being within the community.

NEIWAI

Series C in 2019
NEIWAI is a mid-to-high-end underwear brand founded in Shanghai in 2012, dedicated to providing comfortable clothing that respects the feelings of women. The company emphasizes a design philosophy that harmonizes comfort, function, and beauty, resulting in a diverse range of products suitable for various daily activities, including home and sports. Over the past five years, NEIWAI has served more than 200,000 female customers, reflecting its commitment to meeting the needs of its clientele. By focusing on the comfort of close-fitting clothing, NEIWAI aims to enhance the everyday experiences of its customers through thoughtfully designed underwear.

Yunyinggu

Series C in 2019
Yunyinggu Technology Co., Ltd. is a start-up company dedicated to developing and promoting new display technologies that can significantly improve the performance of flat panel displays. The company's proprietary solution is the world's best in achieving high PPI (pixel per inch) and can be applied to all kinds of flat panels such as LCD, LED, OLED and others. Yunyinggu Technology Co., Ltd. is based in China.

Amphivena Therapeutics

Series C in 2019
Amphivena Therapeutics is a clinical-stage immuno-oncology company focused on developing bifunctional antibody therapies aimed at treating hematologic malignancies. Founded in 2012 and based in South San Francisco, California, the company utilizes its proprietary ReSTORE platform to create dual-action biologics that enhance the patient's immune response against cancer. These therapies are designed to relieve immune suppression while activating T cells, thereby promoting the destruction of tumor cells and their precursors. The platform emphasizes avidity, target selectivity, and safety, and can be engineered to include additional functionalities for targeting solid tumors. As a subsidiary of Affimed N.V., Amphivena Therapeutics aims to provide innovative treatment options for patients facing blood cancers.

Tisenc

Series C in 2019
Founded in 2015, Shenzhen Tisenc Medical Devices Co., Ltd. is a Sino-foreign joint venture. Located in Shenzhen Guangdong, Tisenc Medical devices delicate in the developing, manufacturing and global sales of chemiluminescence Immunology (CLIA) systems. The company provides the product of CLIA system, high-level POCT system, and molecular diagnostics solutions. Tisenc now has R&D labs, GMP factory, Instrument factory for totally over 16000 square meters space. And fully intellectual property right for product and technologies, the company is fully independent for the R&D and production of a product.

Hesai Technology

Series C in 2019
Hesai Technology designs a laser radar that facilitates autonomous driving. It uses smart sensing technology to develop laser radar for autonomous cars and natural gas leak detection systems, enabling car companies to monitor mixed gas composition, control industrial processes and detect hazardous gas leaks.

Haoyiku

Series C in 2019
Haoyiku, founded in 2017 by Qiangqiang Wu and based in Hangzhou, China, operates as a community-based e-commerce platform specializing in apparel. The company is part of the Webuy/Jingling Group, which includes various brands and focuses on social e-commerce. Haoyiku allows merchants to share links to items for sale through WeChat, enabling customers to make direct purchases within the app. This business model leverages social media to enhance the shopping experience and facilitate connections between merchants and consumers.

Haoyiku

Series C in 2019
Haoyiku, founded in 2017 by Qiangqiang Wu and based in Hangzhou, China, operates as a community-based e-commerce platform specializing in apparel. The company is part of the Webuy/Jingling Group, which includes various brands and focuses on social e-commerce. Haoyiku allows merchants to share links to items for sale through WeChat, enabling customers to make direct purchases within the app. This business model leverages social media to enhance the shopping experience and facilitate connections between merchants and consumers.

RedDoorz

Series C in 2019
RedDoorz is an online platform that facilitates budget accommodations across Southeast Asia, catering to both travelers and hoteliers. Founded in 2015 and headquartered in Jakarta, Indonesia, the company operates a network of branded budget hotels, providing its partners with tools for distribution, marketing, technology, customer experience, and pricing. This end-to-end platform allows guest house owners and hotel operators to enhance their visibility, reach a broader audience, and streamline their operations. RedDoorz has expanded significantly, employing over 1,000 individuals across five countries and attracting investment from notable backers. The platform focuses on two-star and three-star budget hotels, enabling travelers to discover affordable lodging options in key business and tourist destinations.

Delta Medical

Series C in 2019
Beijing Delta Medical Co., Ltd. designs and manufactures sports medicine surgical instruments, intraoperative consumables and rehabilitation products. It offer products, such as shoulder arthroscopic instrument, PEEK suture anchor, titanium suture anchor, anterior cruciate ligament and posterior cruciate ligament reconstruction instrument, PEEK interference screw, titanium interference screw, ultra high speed fiber, ultra high speed fiber tape, needle loop, shaver system, arthroscopic hand instrument, medical face shield, and medical eye shield. It also provides sports rehabilitation services. The company is based in Beijing, China.

WorkTrans

Series C in 2019
Shanghai WorkTrans Information Technology Co., Ltd. develops human resource (HR) management software. The company's software solution tracks and analyzes enterprise resource planning (ERP) data and employee performance to estimate the number of work hours and employee skills required in the next phase. It also develops an integrated personnel management platform that integrates payroll, rosters, recruitment, and training solutions. The company was founded in 2015 and is based in Shanghai, China.

Hesai Technology

Series C in 2019
Hesai Technology designs a laser radar that facilitates autonomous driving. It uses smart sensing technology to develop laser radar for autonomous cars and natural gas leak detection systems, enabling car companies to monitor mixed gas composition, control industrial processes and detect hazardous gas leaks.

ZuzuChe

Series C in 2019
ZuzuChe.com is an online taxi search website in China which was founded in Guangzhou in 2011. Business users can use zuzuche.com to search car rental information for designated driving, car chartering, and wedding celebrations in more than 200 cities in China. It aims to provide favorable renting search and booking services for overseas regions, giving business users many different travel choices. With convenient, humanized, and advanced search technology, zuzuche.com integrates information about car renting from the internet and provides users with real-time car renting price checks and comparisons.

Insta360

Series C in 2019
Insta360 is a professional intelligent technology company that offers cameras that empowers people to freely share experiences. The company makes cameras that allow you to share everything, everywhere. From the 8K Insta360 Pro for professional creators, to the matchlessly versatile Insta360 ONE, Insta360's cameras allows to capture big moments in immersive detail. Founded in 2014, Insta360 is the world leader in 360-degree cameras. Based in Shenzhen and immersed in the city’s incomparable hardware ecosystem, Insta360 prides itself on creating groundbreaking products that push the envelope of both performance and accessibility. With an Insta360 camera, users can take 360-degree photos and videos in high definition, and live-stream their experiences directly onto Facebook, Twitter, YouTube and other social platforms. When viewed in a VR headset, Insta360 experiences can transport people into places and moments they’ve never before imagined.

Zuiyou

Series C in 2019
Zuiyou is a social networking mobile application for sharing and discovering content such as recommendations, topics and videos.

Petkit

Series C in 2019
Shanghai PETKIT Network Technology Co., Ltd. Develops and manufactures pet care products. It offers smart antibacterial bowls, smart feeders, smart drinking fountains, pet accompanying cups, smart leashes, smart cat brand dog tags, smart pet companions, multifunctional cat claw plates, etc.; cat and dog tags that record, analyze, and track the pet's usual sports behavior data; and toys. Shanghai PETKIT Network Technology Co., Ltd. was founded in 2013 and is based in Shanghai, China.

Microtech Medical

Series C in 2018
MicroTech Medical founded in January, 2011 in Hangzhou Future Technical City, which is the Industrial Garden for High-level Overseas Talents in Zhejiang Province, recieved capital from Eli Lilly and Company. They devote to innovate and manufacture high-tech and more affordable medical devices related to Diabetes Care.

APT Medical

Series C in 2018
APT Medical Inc. specializes in the research, development, manufacture, and sale of invasive interventional medical devices aimed at treating cardiovascular and cerebrovascular diseases. The company offers a range of products, including electrophysiological catheter delivery systems, radiofrequency ablation and mapping catheters, as well as various vascular intervention products such as diagnostic and treatment tools and intervention accessories. Additionally, APT Medical provides OEM and ODM services for catheter and metal products. Established in 2002 and headquartered in Shenzhen, China, the company operates production facilities in Guanlan, Shenzhen, and Xiangxiang, Hunan, positioning itself as a key player in the minimally invasive medical devices sector.

Akulaku

Series C in 2018
Akulaku Inc. is a consumer finance platform based in Jakarta, Indonesia, established in 2016. The company specializes in offering online financial credit services to customers across Southeast Asia. Its services include shopping in installments through an independently managed online marketplace and various other platforms, as well as providing flexible cash loans. Akulaku's mission is to enhance the quality of life for both partners and consumers by creating a comprehensive and reliable financial ecosystem.

ET Healthcare

Series C in 2018
ET Healthcare, Inc. is an in vitro diagnostics company that specializes in manufacturing central laboratory analyzers for both inpatient and outpatient testing in various medical settings, including hospitals and clinics. The company has developed the Pylon Immunochemistry System, an integrated turnkey solution that addresses the immunodiagnostics needs across several areas, such as inflammation, cardiac function, fertility, infectious diseases, and tumors. Additionally, the Pylon BNP Immunoassay aids in managing heart failure by measuring B-type natriuretic peptide levels in plasma. ET Healthcare’s offerings include a variety of immunoassays for cardiac markers, blood clots, and other health conditions, facilitating simplified blood analysis for physicians. Based in Palo Alto, California, the company also has offices in Shanghai, China, and operates manufacturing facilities in Suzhou, China.

SequoiaDB

Series C in 2018
SequoiaDB Corporation is a distributed database company in China. Its products include SequoiaDB, an enterprise-class distributed relational database for core online transaction, data center, content management, and other application scenarios; and SequoiaCM, an enterprise content management software that solves the challenges faced by large and medium-sized enterprises in storing and managing a large amount of unstructured data. The company provides online transaction business, content management, and data lake solutions. It serves financial institutions, including banking, insurance, and security clients. The company was founded in 2011 and is based in Shenzhen, China.

Jacobio Pharmaceuticals

Series C in 2018
Jacobio Pharmaceuticals Co., Ltd., a clinical-stage pharmaceutical company, focusing on the in-house discovery and development of oncology therapies. Its lead drug development programs include two clinical-stage allosteric SHP2 inhibitors, including JAB-3068, a SHP2 inhibitor for the treatment of patients with solid tumor; and JAB-3312, an oral small molecule anti-tumor agent. The company was founded in 2015 and is based in Beijing, China. Jacobio Pharmaceuticals Co., Ltd. is a subsidiary of Jacobio (HK) Pharmaceuticals Co., Limited.

CANbridge Pharma

Series C in 2018
CANbridge Pharma is a biopharmaceutical company focused on the development and commercialization of healthcare products in China and North Asia, particularly for oncology and rare diseases. Established in 2012 and headquartered in Beijing, with additional offices in Shanghai, Cambridge, Taipei, and Hong Kong, the company partners with Western biopharmaceutical firms to bring clinical-stage pharmaceutical, medical device, and diagnostic products to the region. CANbridge specializes in therapies for serious medical conditions that are either unavailable or inadequately addressed in North Asia. Its key product, CAN008, is a glycosylated CD95-Fc fusion protein aimed at treating glioblastoma multiforme, while the company also has a diverse pipeline of biologics and small molecules targeting conditions such as Hunter Syndrome, hemophilia A, and various rare metabolic disorders. Through licensing and exclusive commercialization agreements, CANbridge seeks to enhance healthcare solutions for underserved patient populations in the region.

Zuiyou

Series C in 2018
Zuiyou is a social networking mobile application for sharing and discovering content such as recommendations, topics and videos.

Moretickets

Series C in 2018
Moretickets is an online ticketing company based In Shanghai.

Lanjinrong

Series C in 2018
Lanjinrong is a Beijing Based Fintech Start Up.

Bang Er Orthopedic

Series C in 2018
Zhejiang Boner Medical Investment Management Co., Ltd. is a well-known professional hospital investment operator in the Yangtze River Delta, featuring major orthopaedics and rehabilitation.

XSKY Data Technology

Series C in 2018
XSky (Beijing) Data Technology Co., Ltd. is a Chinese company specializing in software-defined infrastructure products and services. It offers a range of storage solutions, including XCBS for cloud storage, XEBS for block storage, XEUS for unified storage, XEOS for object storage, and XEDP as a unified data platform. The company also provides software-defined storage solutions with its XSCALER series. XSky serves various sectors, including finance, healthcare, education, telecommunications, and energy, catering to enterprises, government agencies, and media networks. In addition to its product offerings, XSky is a significant contributor to the open-source storage system Ceph and is recognized as a leading partner of Red Hat in China. The company collaborates with major IT firms like Intel and Dell to enhance its technology and solutions, focusing on scalable and future-ready storage options.

CMLabs

Series C in 2018
The Chain Medical Labs is a professional independent medical laboratory established from a team of experienced technical and management experts which is one of the Shanghai Chain medical investment management Inc. also alliance with few internationally renowned lab and vendors. The company utilize advanced testing methods, quality management systems, automation technology as Europe, America and Japan for their Clinical Diagnostics. CMLabs features in clinical laboratory services, clinical trial services, research services, and laboratory information system services to support all medical institutions, as well as assist to obtain ISO15189 certification, CAP accreditation (United States Association of pathology quality system), SOP process and external audit services.

Miaoshou Doctor

Series C in 2018
Miaoshou Doctor is a healthcare service platform for building an online communication service platform between patients and doctors. It helps healthcare professionals and patients to manage post-diagnosis outcomes and allows doctors to actively follow up with their patient's health through additional counseling and prescriptions. Tao He and Daoliang Han founded the company in 2015 and is based in Beijing, Beijing.

Bondent Technology

Series C in 2018
Provider of integrated oral medical solutions for oral health and dental industry. The company offers technical training, operation and management consulting services to their clients. The company also involves in the design, development, manufacturing, and sales of oral medical equipment, providing a full fledged ecosystem for the dental and oral health industry.

Xiaoman Technology

Series C in 2018
Xiaoman Technology is a foreign trade solutions provider that employs the power of big data and artificial intelligence. Its customer-relationship management technology helps enterprises to expand their international business. Xiaoman's products, solutions, and services are highly flexible and compatible, meeting the standardization needs of small and micro enterprises, as well as the customization needs of large and medium-sized enterprises. It has ensured satisfactory service and products to customers through a comprehensive customer-focused R&D, customer service, sales, marketing, and channel organization system. Xiaoman Technology was established in 2013 and is based in Shenzhen, China.

Tiebaobei

Series C in 2017
Tiebaobei is a Beijing-based company that specializes in the trading of used construction equipment. It operates a platform designed to facilitate transactions between buyers and sellers of second-hand machinery, addressing common challenges in the traditional marketplace. By leveraging the internet, Tiebaobei aims to create a more efficient and user-friendly environment for trading construction equipment, catering to a global audience. The company is focused on developing a customer-to-customer (C2C) trading model that enhances fairness and accessibility in the industry.

Bioscience

Series C in 2017
Bioscience integrates R&D, manufacture, marketing and provides related technical supports for IVD instruments and reagents.

Bang Er Orthopedic

Series C in 2017
Zhejiang Boner Medical Investment Management Co., Ltd. is a well-known professional hospital investment operator in the Yangtze River Delta, featuring major orthopaedics and rehabilitation.

Venus MedTech

Series C in 2017
Venus MedTech (Hangzhou) Inc. specializes in the development and sale of transcatheter heart valve medical devices, operating both in Mainland China and internationally. Founded in 2009 and headquartered in Hangzhou, the company offers a range of innovative products, including the VenusA-Valve for treating severe aortic stenosis, the VenusP-Valve for addressing right ventricular outflow tract dysfunction, as well as catheter systems like the V8/TAV8 for balloon aortic valvuloplasty. Additionally, Venus MedTech has developed the TriGUARD3, a cerebral embolic protection device designed to reduce the risk of cerebral damage during heart procedures. The company is also working on product candidates such as VenusA-Plus and VenusA-Pilot, along with transcatheter mitral and tricuspid valve replacement solutions. Positioned within the Hangzhou National High-tech Industrial Development Zone, Venus MedTech aims to meet the growing clinical needs for interventional artificial cardiac valves, a field that is gaining recognition and demand in China and beyond.

Hypereal

Series C in 2017
Hypereal is a virtual reality technology company based in Minhang, China, that specializes in manufacturing and marketing electronic equipment for immersive virtual experiences. It offers a range of products including the HyPano head-mounted display, HyFeels hand controllers, and a comprehensive link center consisting of HyBeacons and Hybox. Hypereal distinguishes itself as the only VR company in China with its own integrated software ecosystem, which encompasses VR headsets, positioning tracking systems, interactive controllers, and a dedicated game development team. As a leader in the Chinese VR/AR sector, the company focuses on developing and producing high-quality products entirely within China.

ARMO BioSciences

Series C in 2017
ARMO Biosciences is a biotechnology company that develops immune modulatory biologic therapeutics. The company is based in Redwood City, California.

SceneRay

Series C in 2017
SceneRay Corporation, Limited is a medical device company based in Suzhou, China, specializing in the design, development, and distribution of neuromodulation devices. The company offers a range of products, including a deep brain stimulation system that features an implantable neuro-stimulator, patient controller, and various accessories. Additionally, SceneRay develops spinal cord stimulation and sacral nerve stimulation systems. The team at SceneRay comprises experts with extensive experience in neuromodulation device development, manufacturing, and marketing, and the company holds numerous patents in this field. Committed to advancing neuromodulation solutions, SceneRay aims to provide patients with high-quality and effective treatments.

Zai Lab

Series C in 2017
Zai Lab Limited is a Shanghai-based biopharmaceutical company founded in 2013, dedicated to discovering, developing, and commercializing innovative therapeutics for oncology, autoimmune, and infectious diseases. The company offers several proprietary products, including Niraparib for treating solid tumors, Optune for glioblastoma multiforme, and Ripretinib for KIT and PDGFRa-driven cancers. Additionally, Zai Lab develops other investigational therapies such as REGN1979, Margetuximab, INCMGA0012, Bemarituzumab, Omadacycline, and Durlobactam. With a focus on the Chinese market, Zai Lab has established partnerships with leading global biopharmaceutical firms to enhance its drug pipeline and improve access to transformative medicines. The company leverages its expertise in drug development and favorable regulatory conditions in China, along with in-house manufacturing capabilities, to support both clinical and commercial production. Zai Lab aims to expand its operations and build a specialized commercial team to effectively market its products in China and beyond.

Wacai

Series C in 2017
Wacai is a Chinese mobile app developer and the creator of a personal finance management mobile app. The app has two major functions. One, to serve as a bookkeeping service (launched in 2009) and two, a mutual fund trading feature that was added in July of 2013. Its most recent feature, incorporated in April of 2014, is a credit card manager, which is gaining popularity in the Chinese markets. The app currently has over 40 million users.

Xueba100

Series C in 2017
Xueba100 is an educational platform that caters to K-12 students in China, specializing in providing software and online services designed to assist junior and senior high school students with their studies. The platform offers a "super scholar" feature that allows students to upload images of challenging homework questions and receive detailed answers and procedures. This service leverages advanced technology, including STR Technology and deep learning models, to enhance character recognition and improve the accuracy of responses. In addition to its homework assistance, Xueba100 collaborates with experienced instructors to create customized curricula across various subjects, delivering comprehensive educational resources and test preparation tools to support students' learning needs.

Chushou

Series C in 2017
Chushou is a Chinese social networking platform with 2.7 million live video streaming hosts on its platform with daily active hosts of 150,000.

Face++

Series C in 2016
Incorporated in 2011, Megvii is committed to make greatest value for customers and the whole society with extraordinary technology. Megvii is an Artificial Intelligence company specialized in providing enterprises and developers with intelligent solutions and data services, and is dedicated to the mission of “Create machines that can see and think”. Based on its original deep learning system Brain++, Megvii seeks to build AI Engine, a core fundamental technology powering various AI application. It is leveraging on recognition, control, optimization and other algorithms to connect individuals, objects and scenarios, building a product platform of IoT OS. It is connecting standardized hardware like sensors, robots and personal devices with AI+IoT (AIoT), thus commercializing three application-oriented IoT brains on a large scale, namely, city brain, supply chain brain, and personal life brain. Megvii is building an operation system for the era of AIoT. Megvii is an AIoT solutions expert.

Bondent Technology

Series C in 2016
Provider of integrated oral medical solutions for oral health and dental industry. The company offers technical training, operation and management consulting services to their clients. The company also involves in the design, development, manufacturing, and sales of oral medical equipment, providing a full fledged ecosystem for the dental and oral health industry.

Mobike

Series C in 2016
Meituan Bike (formerly Mobike) is a Chinese fully station-less bicycle-sharing system. It develops mobile apps for users to find and use bicycles to travel anywhere. Davis Wang Xiao Feng, Hu Wei Wei, and Xia Yi Ping founded Mobike on January 27, 2015, with its headquarters in Beijing, China. Mobike raised $600 million in Series E funding led by Tencent, bringing the firm's fundraising in 2017 alone to nearly US$1 billion in June 2017. It became worth US$3 billion in the same month. Chinese web company Meituan-Dianping acquired Mobike for US$2.7 billion in April 2018. Parent company Meituan-Dianping announced name change from Mobike to Meituan Bike on January 23, 2019 as part of an ongoing integration.

Ruhnn

Series C in 2016
Ruhnn Holding Limited, together with its subsidiaries, operates key opinion leader (KOL) cultivation and incubation platforms in the People's Republic of China. The company engages in the sale of various fashion and lifestyle products to consumers through its KOL online stores; and provision of various KOL sales and advertising services to third-party merchants. Its online stores primarily provide women's apparel, cosmetics, shoes, and handbags. As of March 31, 2020, it owned and operated 19 online stores; and had 168 signed KOLs. The company was founded in 2016 and is headquartered in Hangzhou, the People's Republic of China.

Musical.ly

Series C in 2016
Musical.ly, founded in 2014 by Alex Zhu and Luyu Yang, was a video social network that enabled users to create, share, and discover short videos, primarily catering to a teenage audience. The platform allowed users to express themselves through various forms of creativity, including singing, dancing, comedy, and lip-syncing, with videos limited to 15 seconds. Since its launch, Musical.ly gained significant popularity, becoming the top free app in the iOS App Store in 20 countries, including the United States. The app fostered a global community for content creators and users alike. In 2017, Musical.ly was acquired by a subsidiary of ByteDance, and in 2018, it was merged into TikTok, further expanding its reach and influence in the social media landscape.

Bilibili

Series C in 2016
Bilibili Inc. is an online entertainment platform based in Shanghai, China, catering primarily to the younger generation. Founded in 2009, the company has evolved from a niche content community focused on anime, comics, and games (ACG) into a comprehensive entertainment hub that offers a diverse range of media formats, including videos, live broadcasts, and mobile games. Bilibili emphasizes high-quality content and aims to create immersive experiences that foster strong emotional connections among its users. The platform features a unique interactive playback system that allows for real-time subtitle overlays, enhancing user engagement. Additionally, Bilibili has established a strategic collaboration with Tencent for the sharing and operation of anime and games, further expanding its content offerings and reach within the Chinese market.

Tiebaobei

Series C in 2016
Tiebaobei is a Beijing-based company that specializes in the trading of used construction equipment. It operates a platform designed to facilitate transactions between buyers and sellers of second-hand machinery, addressing common challenges in the traditional marketplace. By leveraging the internet, Tiebaobei aims to create a more efficient and user-friendly environment for trading construction equipment, catering to a global audience. The company is focused on developing a customer-to-customer (C2C) trading model that enhances fairness and accessibility in the industry.

FraudMetrix

Series C in 2016
Hangzhou FraudMetrix is a Chinese company engaged in the development of security products against internet risks and fraud. FraudMetrix is dedicated to solving problems such as internet risks and fraud, so as to bring value for enterprises with data intelligence. It covers antifraud areas including account fraud, transaction fraud, payment fraud, business fraud, internet credit fraud, and corporate internal fraud. FraudMetrix is focused on catering to the diversified needs of corporate risk management. FraudMetrix was founded in 2013 by a group of antifraud scientists and technology executives of the former Ali Group Security Department, PayPal, and RSA.

Lagou

Series C in 2016
Lagou.com operates a recruitment website and offers staffing services. The company’s clientele includes Tencent, Baidu, Alibaba Group, SINA, JD.com, Beijing Xiaomi Tech, and Zhaopin.com. Lagou.com was founded in 2013 and is based in Beijing, China.

Cehome

Series C in 2016
Cehome was established in 2009 by the founder and CEO Fan Construction to create armor and armor forum. Since its inception, armored to intentions to serve users and promote industry progress as its mission, committed to using the Internet to promote the development of China's construction machinery industry.

Aohua

Series C in 2016
Aohua Endoscopy Co., Ltd. is a manufacturer of endoscopy equipment and consumables, offering a range of products including imaging processors, endoscopes, and various accessories. The company specializes in solutions for gastroenterology, respiratory care, ear, nose, and throat (E.N.T) applications, as well as veterinary endoscopy. Founded in 1994, Aohua is headquartered in Shanghai, China, and aims to lead in the innovation of endoscope technology while advancing the field of endoscopic diagnosis and treatment.

Nurotron Biotechnology

Series C in 2015
Hangzhou Nurotron Biotechnology Co., Ltd., (诺尔康神经电子科技) is a high-tech enterprise providing nerve electronic products. The company is mainly involved in the R&D of multipath manual electrical cochlea systems, nationalization and clinical application of auditory brainstem implant equipment, strategy and technology enhancement of home-grown manual cochlea, and more. The company’s headquarters and production base are located in Hangzhou, China, and its R&D center is located in California, USA.

Zhihu

Series C in 2015
Zhihu (知乎) is a Chinese socialized website for questions and answers. It differs from traditional online question and answer forums by enabling users to obtain information through questions that provoke the opinions and views from answerers as individuals. The number of registered users on Zhihu has surpassed 300,000 by the end of January 2012. Zhihu was founded in 2011.

CanSinoBIO

Series C in 2015
Tianjin CanSino Biotech Inc. is an emerging biotechnology company dedicated to vaccine research, development and commercialization. We seek to address the pressing unmet medical needs by developing and marketing leading-edge, high quality vaccines for China and other emerging markets at affordable prices.

Wealth Bridge

Series C in 2015
Wealth Bridge is a software that helps financial managers improve the efficiency of their services for customers.

Tuhu

Series C in 2015
Tuhu offers same-day or next-day automobile after-sales product delivery and installation services in more than 260 cities across mainland China. The company provides its services via its website, mobile app, call center, and third-party e-commerce platforms.

Bilibili

Series C in 2015
Bilibili Inc. is an online entertainment platform based in Shanghai, China, catering primarily to the younger generation. Founded in 2009, the company has evolved from a niche content community focused on anime, comics, and games (ACG) into a comprehensive entertainment hub that offers a diverse range of media formats, including videos, live broadcasts, and mobile games. Bilibili emphasizes high-quality content and aims to create immersive experiences that foster strong emotional connections among its users. The platform features a unique interactive playback system that allows for real-time subtitle overlays, enhancing user engagement. Additionally, Bilibili has established a strategic collaboration with Tencent for the sharing and operation of anime and games, further expanding its content offerings and reach within the Chinese market.